CDSCO UID IMP/IVD/2023/000280_624460c775e15528857c924c34401966_b1b44ceee810d835ed7d2d6e82753c67
LYSE(Lyse )
GOSWAMI INC·Device Class Class B·India CDSCO·Brand: Z5 DN
Registration details
- UID
- IMP/IVD/2023/000280_624460c775e15528857c924c34401966_b1b44ceee810d835ed7d2d6e82753c67
- Device class
- Class B
- Brand name
- Z5 DN
- License holder
- GOSWAMI INC
- Approving authority
- CDSCO
- Product information
- It's used to break down red blood cell membrane to release hemoglobin before blood cell analysis. It also could shrink other WBC cells except basophils while keeps the original volume of basophils. The instrument detects hemoglobin concentration, and classifies basophile and count total white blood cell via distinguishing the morphological differences among cell volume and cellular complexity
Similar products (2)
Other products with the same name or brand
DILUENT(Diluent )
Brand: Z5 DN
GOSWAMI INC
Class B
LYSE(Lyse )
Brand: Z5 DN
GOSWAMI INC
Class B
Other products from GOSWAMI INC
Products from the same license holder (5 products)
Chemistry Analyzer
Brand: Z50 HEMATOLOGY ANALYZER
Class A
DILUENT(Diluent )
Brand: Z5 DN
Class B
LYSE(Lyse )
Brand: Z5 DN
Class B
HEMATOLOGY ANALYZER
Brand: Z50 HEMATOLOGY ANALYZER
Class A
HEMATOLOGY ANALYZER
Brand: Z50 HEMATOLOGY ANALYZER
Class A
About this record
LYSE(Lyse ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000280_624460c775e15528857c924c34401966_b1b44ceee810d835ed7d2d6e82753c67. This device is marketed under the brand name Z5 DN. The license holder is GOSWAMI INC, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.